Clinical Ophthalmology

Femtosecond Laser in Lens Surgery: Contribution to Emmetropia

The achievement of emmetropia has been one of the oldest dreams in ophthalmology. This goal involves the correction of any refractive error, and by extension, age-related presbyopia. It is also presently established that lens surgery holds the title of the best available and definitive technique to address presbyopia correction, whether in the presence of a cataract or a transparent crystalline lens. In this quest, femtosecond laser technology arose, enabling competing indexes of reproducibility, precision, efficacy, and customization regarding the several steps involved in lens surgery. The present Article Collection will serve the purpose of providing further illumination on the role of femtosecond laser in lens surgery and stimulating new developments of this technology.

The advent of premium IOLs in the context of refractive lens exchange has triggered demands for a higher standard of surgical procedure; hence the concept of premium lens surgery. Cataract surgery itself has shifted goals in the direction of the best refractive correction. Independency of spectacles by means of surgical intervention has become the desire of an increasingly significant part of the population. The high levels of reproducibility and customization of femtosecond laser-assisted technology are liable to open new horizons in the domain of refractive lens surgery.

Topics of interest include:

• Approaches to the different types of femtosecond laser (fs) pulse energy pattern (low or high) reporting their similarities and differences in all kinds of outcomes.
• Reviews (preferably systematic) and/or meta-analyses on the subject with well-defined references to the studied fs platform(s).
• Emphasis on the refractive outcomes of femtosecond laser-assisted lens surgery, either in the context of cataract or, preferably, refractive lens exchange.
• New incomes to premium lens surgery, in the context of femtosecond laser lens surgery, such as Artificial Intelligence (AI).
• Further developments on fs technology as to permit “zero” phaco, i. e., the feasibility of femtosecond machine’s full autonomy.
• Improvements on fs platforms (portability) and cost-effectiveness strategies.
• The birth of new premium IOLs, as thrusted by fs technology.

We welcome original research articles, reviews, editorials, commentaries, clinical trial reports, and protocols. Please note that all meta-analyses require a pre-submission check. Complete the pre-submission check form before submitting.

Submission Instructions:

Please submit your manuscript through the Dovepress website. During submission, enter the promo code PCKXI for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission. Standard Article Publishing Charges apply.

The manuscript submission deadline is 1 November 2025.

If you have any questions about this Article Collection, please contact Krista Thom at Krista.Thom@taylorandfrancis.com.

Guest Advisors:

Ramiro Salgado, M.D., earned his degree in medicine from the University of Porto in 1990, and his specialist degree in ophthalmology in 2004. Since 2003, he has served as an ophthalmologist at the Hospital da Luz, and is now a senior consultant. He specializes in implant refractive surgery and cornea surgery.

Antonio A.P. Marinho, M.D., Ph.D., is the Chairman of the Department of Ophthalmology, Hospital Luz Arrabida, Porto, Portugal. He earned his M.D. in 1978, and his Ph.D. in 1990. His main research interest is refractive surgery.

Alireza Mirshahi, M.D., Ph.D., is the Director of the Dardenne Eye Clinic in Bonn, Germany. His research interests include cataract surgery and femtosecond lasers for eye surgery.

Disclosure Statement: Alireza Mirshahi is an advisor to Ziemer Ophthalmic Systems, Germany.

Ramiro Salgado and Antonio A. P. Marinho declare no conflicts of interest.